Citations

Showing 10 of 108081 citations.

Well-Being in Graduate Medical Education: A Call for Action
Ripp, Jonathan A., Privitera, Michael R. , Leiter, Richard E. , Logio, Lia , Shapiro, Jo , Bazari, Hasan, West, Colin P.

Mayo Clinic

Academic Medicine | May 3, 2017 | Volume: 92 | Issue: 7 | Pages: 914-917

10.1097/acm.0000000000001735 | PMID 28471780 Get It

Job burnout is highly prevalent in graduate medical trainees. Numerous demands and stressors drive the development of burnout in this population, leading to significant and potentially tragic consequences, not only for trainees but also for the patients and communities they serve. The literature on interventions to reduce resident burnout is limited but suggests that both individual- and system-level approaches are effective. Work hours limitations and mindfulness training are each likely to have modest benefit. Despite concerns that physician trainee wellness programs might be costly, attention to physician wellness may lead to important benefits such as greater patient satisfaction, long-term physician satisfaction, and increased physician productivity. A collaborative of medical educators, academic leaders, and researchers recently formed with the goal of improving trainee well-being and mitigating burnout. Its first task is outlining this framework of initial recommendations in a call to action. These recommendations are made at the national, hospital, program, and nonwork levels and are meant to inform stakeholders who have taken up the charge to address trainee well-being. Regulatory bodies and health care systems need to be accountable for the well-being of trainees under their supervision and drive an enforceable mandate to programs under their charge. Programs and individuals should develop and engage in a “menu” of wellness options to reach a variety of learners and standardize the effort to ameliorate burnout. The impact of these multilevel changes will promote a culture where trainees can learn in settings that will sustain them over the course of their careers.
Rendered Speechless
Cowdell, Jed C. , Burton, M. Caroline , Holmes‐Maybank, Keri T. , Harte, Brian , Josephson, S. Andrew , Harris, Dana, Harris, Dana M.

Mayo Clinic

Journal of Hospital Medicine | May 3, 2017 | Volume: 12 | Issue: 5 | Pages: 352-355

10.12788/jhm.2742 | PMID 28459907 Get It

Gowers and Osler: Good friends ‘all through'
Boes, CJ

Mayo Clinic

Journal of the Royal College of Physicians of Edinburgh | May 3, 2017 | Volume: 46 | Issue: 1 | Pages: 55-64

10.4997/jrcpe.2016.112 | PMID 27092371 Get It

William Gowers and William Osler first met in 1878, and Osler visited Gowers often when in London. Osler dedicated his book On Chorea and Choreiform Affections to Gowers in 1894, addressing himself as Gowers’ sincere friend. Two warm letters between Osler and Gowers exist in the Osler Library Archives, highlighting their strong friendship, and Gowers’ son Ernest wrote Osler a letter after the death of his father. Referring to the relationship between William Osler and William Gowers, he noted that Osler had indeed been a good friend to him all through. Osler wrote and edited the first edition of his textbook from 1890 through early 1892, and was influenced by Gowers’ Manual of Diseases of the Nervous System. In 1913, Osler commented that Gowers had ataxic paraplegia. Macdonald Critchley disagreed, and felt that Gowers had generalised cerebrovascular degeneration. Osler and Gowers were close friends, and this friendship was mutually beneficial.
A Practical Framework for Understanding and Reducing Medical Overuse: Conceptualizing Overuse Through the Patient‐Clinician Interaction
Morgan, Daniel J., Leppin, Aaron L. , Smith, Cynthia D. , Korenstein, Deborah R.

Mayo Clinic

Journal of Hospital Medicine | May 3, 2017 | Volume: 12 | Issue: 5 | Pages: 346-351

10.12788/jhm.2738 | PMID 28459906 Get It

Overuse of medical services is an increasingly recognized driver of poor‐quality care and high cost. A practical framework is needed to guide clinical decisions and facilitate concrete actions that can reduce overuse and improve care. We used an iterative, expert‐informed, evidence‐based process to develop a framework for conceptualizing interventions to reduce medical overuse. Given the complexity of defining and identifying overused care in nuanced clinical situations and the need to define care appropriateness in the context of an individual patient, this framework conceptualizes the patient–clinician interaction as the nexus of decisions regarding inappropriate care. This interaction is influenced by other utilization drivers, including healthcare system factors, the practice environment, the culture of professional medicine, the culture of healthcare consumption, and individual patient and clinician factors. The variable strength of the evidence supporting these domains highlights important areas for further investigation.
Age may contribute to the increased frequency of axonal Guillain‐Barré syndrome
Wilken, Miguel , Hawkes, Maximiliano A. , Navarrete‐Vázquez, Gabriel , Farez, Mauricio

Mayo Clinic

Muscle & Nerve | May 3, 2017 | Volume: 56 | Issue: 6 | Pages: 1171-1173

10.1002/mus.25679 | PMID 28467012 Get It

ABSTRACTIntroductionThe frequency of axonal Guillain‐Barré syndrome (GBS) varies among countries. Previous studies supporting the high frequency of axonal GBS in South America have been carried out with pediatric populations. We seek to determine the frequency of axonal GBS in both children and adults in South America.MethodsThis is a retrospective cohort analysis of patients who were diagnosed with GBS between January 2006 and December 2013 in a neurological center in Buenos Aires, Argentina. Adults and children with a diagnosis of GBS were included and classified by applying Ho and colleagues' criteria1 for axonal GBS.ResultsThe study included 105 patients with GBS. Among 58 adults, only 5 individuals were classified as axonal GBS compared with 16 of 47 children. The frequency of axonal GBS was significantly higher in children than in adults (34% vs. 8.6%, P = 0.0001).DiscussionAs shown in a cohort of South American patients, age may impact the frequency of axonal GBS. Muscle Nerve 56: 1311–1313, 2017
Risk of histological transformation and therapy‐related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma
Epperla, Narendranath , Pham, Anthony , Burnette, Brian L., Wiseman, Gregory A., Macon, William R. , Ansell, Stephen M. , Inwards, David J. , Micallef, Ivana N. , Johnston, Patrick B. , Porrata, Luis F. , Ristow, Kay M., Nowakowski, Grzegorz S. , Pham, Anthony Q, Colgan, Joseph P. , Habermann, Thomas M. , Markovic, Svetomir N. , Witzig, Thomas E. , Epperla, Narendranath

Mayo Clinic

British Journal of Haematology | May 3, 2017 | Volume: 178 | Issue: 3 | Pages: 427-433

10.1111/bjh.14688 | PMID 28466487 Get It

SummaryHistological transformation (HT) of follicular lymphoma (FL) to an aggressive lymphoma after chemotherapy remains a key issue. The incidence of HT after radioimmunotherapy (RIT) is unknown. This single institution study analysed the risk of HT in FL after treatment with yttrium‐90 ibritumomab tiuxetan in 115 consecutive patients treated during 1987–2012. RIT was administered for progressive FL in 111 (97%) patients and as first‐line therapy in the remaining 4. 28% (n = 32) had HT, occurring at a median of 60 months from diagnosis and 20 months after RIT. 48% (12/25) of patients who received fludarabine developed HT. The estimated 10‐year risk of HT in the fludarabine and non‐fludarabine groups was 67% and 26% respectively (P = 0·015). Only prior fludarabine was significantly associated with predicting the risk of HT after RIT. 8% (9/115) of patients developed therapy‐related myelodysplastic syndrome/acute myeloid leukaemia (tMDS/AML) at a median of 41·4 months (range, 5–89). The estimated 10‐year risk of tMDS/AML in non‐fludarabine treated patients (n = 90) versus fludarabine treated (n = 25) was 13% and 29%, respectively. The estimated overall risk of FL undergoing HT at 10 years without fludarabine exposure appears similar to patients reported in the literature that have not received RIT. Patients with prior purine‐analogue therapy are at significantly higher risk of HT.
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Höglinger, Günter U. , Respondek, Gesine , Stamelou, María , Kurz, Carolin , Josephs, Keith A. , Lang, Anthony E. , Mollenhauer, Brit , Müller, Ulrich , Whitwell, Jennifer L. , Arzberger, Thomas, Englund, Elisabet , Gelpí, Ellen , Irwin, David J. , Meissner, Wassilios G. , Pantelyat, Alexander , Rajput, Alex, Swieten, John C. van, Troakes, Claire , Antonini, Angelo , Bordelon, Yvette , Compta, Yaroslau , Corvol, Jean‐Christophe , Dodel, Richard , Ferguson, Leslie W. , Kassubek, Jan , Krismer, Florian , Xiong, Chengjie , Lorenzl, Stefan , Morris, Huw R. , Nestor, Peter J. , Oertel, Wolfgang H., Rabinovici, Gil D. , Rowe, James B. , Schellenberg, Gerard D., Seppi, Klaus , Eimeren, Thilo van , Wenning, Gregor K. , Boxer, Adam L. , Golbe, Lawrence I. , Group, for the Movement Disorder Society–endorsed PSP Study, Meissner, Wassilios G , Bhatia, Kailash P , Nilsson, Christer C. , Giese, Armin , Swieten, John C. van , Bhatia, Kailash P. , Colosimo, Carlo , Dickson, Dennis W. , Grossman, Murray , Krismer, Florian , Poewe, Werner H , Schellenberg, Gerard D., Litvan, Irene , Group, for the Movement Disorder Society–endorsed PSP Study, Höglinger, Günter U , Lang, Anthony E , Irwin, David J , Antonini, Angelo , Rowe, James B , Corvol, Jean-Christophe , Seppi, Klaus , Xiong, Chengjie , Gelpi, Ellen , Pantelyat, Alex , Rabinovici, Gil D , Troakes, Claire , Morris, Huw R , van Eimeren, Thilo

Mayo Clinic

Movement Disorders | May 3, 2017 | Volume: 32 | Issue: 6 | Pages: 853-864

10.1002/mds.26987 | PMID 28467028 Get It

ABSTRACT Background : PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome. Objective : We aimed to provide an evidence‐ and consensus‐based revision of the clinical diagnostic criteria for PSP. Methods : We searched the PubMed, Cochrane, Medline, and PSYCInfo databases for articles published in English since 1996, using postmortem diagnosis or highly specific clinical criteria as the diagnostic standard. Second, we generated retrospective standardized clinical data from patients with autopsy‐confirmed PSP and control diseases. On this basis, diagnostic criteria were drafted, optimized in two modified Delphi evaluations, submitted to structured discussions with consensus procedures during a 2‐day meeting, and refined in three further Delphi rounds. Results : Defined clinical, imaging, laboratory, and genetic findings serve as mandatory basic features, mandatory exclusion criteria, or context‐dependent exclusion criteria. We identified four functional domains (ocular motor dysfunction, postural instability, akinesia, and cognitive dysfunction) as clinical predictors of PSP. Within each of these domains, we propose three clinical features that contribute different levels of diagnostic certainty. Specific combinations of these features define the diagnostic criteria, stratified by three degrees of diagnostic certainty (probable PSP, possible PSP, and suggestive of PSP). Clinical clues and imaging findings represent supportive features. Conclusions : Here, we present new criteria aimed to optimize early, sensitive, and specific clinical diagnosis of PSP on the basis of currently available evidence. © 2017 International Parkinson and Movement Disorder Society
Landmarks for Identifying the Suprascapular Foramen Anteriorly: Application to Anterior Neurotization and Decompressive Procedures
Manouvakhova, Olga V, Macchi, Veronica , Fries, Fabian N. , Loukas, Marios , Oskouian, Rod J. , Spinner, Robert J. , Tubbs, R. Shane , Manouvakhova, Olga , De, Raffaele

Mayo Clinic

Operative Neurosurgery | May 3, 2017 | Volume: 14 | Issue: 2 | Pages: 166-170

10.1093/ons/opx096 | PMID 29351679 Get It

Abstract BACKGROUND Additional landmarks for identifying the suprascapular nerve at its entrance into the suprascapular foramen from an anterior approach would be useful to the surgeon. OBJECTIVE To identify landmarks for the identification of this hidden site within an anterior approach. METHODS In 8 adult cadavers (16 sides), lines were used to connect the superior angle of the scapula, the acromion, and the coracoid process tip thus creating an anatomic triangle. The suprascapular nerve's entrance into the suprascapular foramen was documented regarding its position within this anatomical triangle. Depths from the skin surface and specifically from the medial-most point of the clavicular attachment of the trapezius to the suprascapular nerve's entrance into the suprascapular foramen were measured using calipers and a ruler. The clavicle was then fractured and retracted superiorly to verify the position of the nerve's entrance into the suprascapular foramen. RESULTS From the trapezius, the nerve's entrance into the foramen was 3 to 4.2 cm deep (mean, 3.5 cm). The mean distance from the tip of the corocoid process to the suprascapular foramen was 3.8 cm. The angle best used to approach the suprascapular foramen from the surface was 15° to 20°. CONCLUSION Based on our study, an anterior suprascapular approach to the suprascapular nerve as it enters the suprascapular foramen can identify the most medial fibers of the trapezius attachment onto the clavicle and insert a finger at an angle of 15° to 20° laterally and advanced to an average depth of 3.5 cm.
Adult extracorporeal membrane oxygenation: an international survey of transfusion and anticoagulation techniques
Esper, Stephen A. , Wallisch, William John , Waters, Jonathan H. , Triulzi, Darrell J., Schears, Gregory J. , Esper, S A , Welsby, Ian J , Subramaniam, Kathirvel , Levy, Jerrold H. , Hayanga, J.W. Awori

Mayo Clinic

Vox Sanguinis | May 3, 2017 | Volume: 112 | Issue: 5 | Pages: 443-452

10.1111/vox.12514 | PMID 28466601 Get It

Background and objectivesExtracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure, with or without cardiac failure. When used for hemodynamic support, the ECMO circuit presents a non‐endothelialized, artificial surface to blood inciting an inflammatory response which activates haemostatic pathways. Anticoagulation may complicate a pre‐existing coagulopathy and/or inadequate surgical hemostasis of varying severity. There is no standardized method to achieve and monitor anticoagulation or guide transfusion therapy during ECMO. We tested the hypothesis that institutions across the world conduct similar management of anticoagulation and transfusion during adult ECMO support.MethodsThis is a descriptive, self‐reporting cross‐sectional survey of anticoagulation and transfusion practice for patients age 18 or older on ECMO. This 38 multiple‐choice question survey was sent to 166 institutions, internationally, utilizing adult ECMO. About 32·4% (54) of institutions responded. Responses were anonymously collected. Descriptive analyses were calculated.ResultsOur findings indicate there appears to be a significant practice variation among institutions regarding anticoagulation and transfusion during adult ECMO support.DiscussionThe lack of standard practices among institutions may reflect a paucity of data regarding optimal anticoagulation and transfusion for patients requiring ECMO. Standardized protocols for anticoagulation and transfusion may help increase quality of care for and reduce morbidity, mortality and cost to patients and healthcare centres. Further study is required for standardized, high quality care.